Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory evaluation of Glybera in Europe - two committees, one mission.
Melchiorri D, Pani L, Gasparini P, Cossu G, Ancans J, Borg JJ, Drai C, Fiedor P, Flory E, Hudson I, Leufkens HG, Müller-Berghaus J, Narayanan G, Neugebauer B, Pokrotnieks J, Robert JL, Salmonson T, Schneider CK. Melchiorri D, et al. Among authors: hudson i. Nat Rev Drug Discov. 2013 Sep;12(9):719. doi: 10.1038/nrd3835-c1. Epub 2013 Aug 19. Nat Rev Drug Discov. 2013. PMID: 23954897 No abstract available.
The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for human use.
Péan E, Flores B, Hudson I, Sjöberg J, Dunder K, Salmonson T, Gisselbrecht C, Laane E, Pignatti F. Péan E, et al. Among authors: hudson i. Oncologist. 2013;18(5):625-33. doi: 10.1634/theoncologist.2013-0020. Epub 2013 Apr 24. Oncologist. 2013. PMID: 23615696 Free PMC article.
The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
Nieto M, Demolis P, Béhanzin E, Moreau A, Hudson I, Flores B, Stemplewski H, Salmonson T, Gisselbrecht C, Bowen D, Pignatti F. Nieto M, et al. Among authors: hudson i. Oncologist. 2016 Jun;21(6):692-700. doi: 10.1634/theoncologist.2015-0298. Epub 2016 Apr 18. Oncologist. 2016. PMID: 27091416 Free PMC article.
UK medicines regulation: responding to current challenges.
Richards N, Hudson I. Richards N, et al. Among authors: hudson i. Br J Clin Pharmacol. 2016 Dec;82(6):1471-1476. doi: 10.1111/bcp.13077. Epub 2016 Sep 8. Br J Clin Pharmacol. 2016. PMID: 27580254 Free PMC article. Review.
The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
Nieto M, Calvo G, Hudson I, Feldschreiber P, Brown D, Lee CC, Lay G, Valeri A, Abadie E, Thomas A, Pignatti F. Nieto M, et al. Among authors: hudson i. Haematologica. 2011 Sep;96(9):e33-40. doi: 10.3324/haematol.2011.048819. Epub 2011 Jun 28. Haematologica. 2011. PMID: 21712542 Free PMC article. Review.
Alteplase for ischaemic stroke--responses.
Hudson I. Hudson I. Lancet. 2014 Aug 23;384(9944):662-3. doi: 10.1016/S0140-6736(14)61388-X. Lancet. 2014. PMID: 25152268 No abstract available.
Valproate and the Pregnancy Prevention Programme.
Morgan S, Raine J, Hudson I. Morgan S, et al. Among authors: hudson i. Br J Gen Pract. 2019 May;69(682):229. doi: 10.3399/bjgp19X702377. Br J Gen Pract. 2019. PMID: 31023671 Free PMC article. No abstract available.
179 results